VEC.L Share News (VEC)
VEC Share
VEC Share
VEC Share
VEC Share
VEC
VEC Share
VEC Broker
VEC Directors
VEC Financial
VEC
VEC Short
VEC
* Approvals for inhaled drugs from GSK, Novartis, SkyePharma * SkyePharma shares up more than 15 percent (Adds detail on Novartis drug, SkyePharma share price jump) LONDON, Sept 20 (Reuters) - Japan has approved three new lung drugs from Western companies, underscoring how the world
Read more
African Minerals: Investec reduces target price from 393p to 246p, while its buy recommendation remains unchanged. Ashmore Group: Berenberg cuts target price from 500p to 470p and retains a buy recommendation. ASOS: Deutsche Bank raises target price from 4450p to 4800p and reiterates a hold recomm
Read more* No increased risk seen with Boehringer's Spiriva Respimat * New study contrasts with safety concerns raised in 2011 LONDON, Sept 8 (Reuters) - A major study on the safety of a mist inhaler used to treat chronic lung disease has found it does not increase the risk of patients dying e
Read moreAMEC: Nomura reduces target price from 1300p to 1230p, while reiterating its buy recommendation. Antofagasta: Exane cuts target price from 1200p to 1100p maintaining an outperform rating. Ashtead Group: JP Morgan shifts target price from 729p to 734p and keeps a neutral rating. Associated British
Read moreRespiratory drug developer Vectura has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its new inhaled pulmonary treatment being tested by Novartis. The FTSE Small Cap company reported that the European Medicines Agency's CHMP gave its positive opinion
Read moreLONDON, July 26 (Reuters) - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro Breezhaler. Also known as QVA149, the once-daily medicine belongs to a new type of dual-
Read moreAberdeen Asset Management: JP Morgan reduces target price from 573p to 476p and reiterates its overweight rating. Ashmore Group: JP Morgan cuts target price from 410p to 339p maintaining a neutral rating. ASOS: Jefferies raises target price from 2199p to 6200p and upgrades from underperform to buy
Read moreAshtead Group: Jefferies takes target price from 690p to 750p and leaves its buy recommendation unchanged. ASOS: Deutsche Bank increases target price from 3300p to 3800p and reiterates a hold recommendation. Atkins: Liberum Capital takes target price from 1020p to 1100p and maintains a buy recomme
Read moreASOS: HSBC Holdings increases target price from 3660p to 4380p and keeps an overweight rating. Bellway: Deutsche Bank raises target price from 1482p to 1503p and reiterates a hold recommendation. Betfair Group: Citi ups target price from 880p to 950p, upgrading from neutral to buy. Capco: UBS inc
Read moreAfferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.
Read moreThe FTSE small cap index trade flat around by mid-session, outperforming the mid-caps and the blue chips, down 0.2 percent and 0.1 percent respectively. Quindell Portfolio surges 18 percent after the management of the outsourcing technology firm issues after issuing more details on an equit
Read moreAggreko: Panmure Gordon reduces target price from 2159p to 1935p, while keeping a hold recommendation. Investec downgrades to hold. Amara Mining: Investec starts with a target price of 89p and a buy rating. ASOS: Goldman Sachs increases target price from 3200p to 3600p and recommends a strong buy.
Read moreAggreko: Berenberg initiates with a target price of 2010p and a hold recommendation. APR Energy: Berenberg starts with a target price of 610p and a sell recommendation. Babcock International Group: Berenberg initiates with a target price of 1180p and a buy recommendation. Barclays: UBS raises tar
Read moreAveva Group: UBS raises target price from 1740p to 1810p and downgrades from neutral to sell. Balfour Beatty: Berenberg downgrades from buy to hold. Bovis Homes Group: Deutsche Bank raises target price from 578p to 599p and maintains buy rating. BTG: Deutsche Bank raises target price from 394p to
Read moreShares of Cambridge-based Vectura rose after it confirmed the Japanese government has approved its Seebri inhalation capsules used in inhaler devices. The shares rose 2p to 86.5p, on news that government clearance will trigger a £2.5m milestone payment for Vectura from its partner Novartis. Whethe
Read more